|
ZNF441 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.780500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.076200E-03 |
| Normal-vs-Stage2 |
1.105730E-02 |
| Normal-vs-Stage3 |
1.013920E-04 |
| Normal-vs-Stage4 |
2.368400E-04 |
| Stage1-vs-Stage2 |
8.025400E-01 |
| Stage1-vs-Stage3 |
3.019700E-02 |
| Stage1-vs-Stage4 |
6.749800E-02 |
| Stage2-vs-Stage3 |
2.082200E-01 |
| Stage2-vs-Stage4 |
2.096200E-01 |
| Stage3-vs-Stage4 |
8.585200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.232700E-04 |
| Normal-vs-AfricanAmerican |
3.507700E-02 |
| Normal-vs-Asian |
3.595700E-02 |
| Caucasian-vs-AfricanAmerican |
9.036000E-01 |
| Caucasian-vs-Asian |
1.881430E-01 |
| AfricanAmerican-vs-Asian |
4.849200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.322400E-03 |
| Normal-vs-Female |
3.390300E-04 |
| Male-vs-Female |
7.096100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.558900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.987700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.977900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.224200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.115600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.065000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.848240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.426200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.401000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.939600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.4473999999941E-06 |
| Classical-VS-Follicular |
6.538000E-01 |
| Classical-VS-Other |
7.251600E-01 |
| Classical-VS-Normal |
3.538900E-03 |
| Tall-VS-Follicular |
3.76050000000516E-05 |
| Tall-VS-Other |
8.518100E-02 |
| Tall-VS-Normal |
9.06570000180906E-08 |
| Follicular-VS-Other |
8.526400E-01 |
| Follicular-VS-Normal |
1.162460E-02 |
| Other-VS-Normal |
3.653400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.150900E-04 |
| Normal-vs-N1 |
1.996880E-03 |
| N0-vs-N1 |
5.476200E-01 |
|
|
